Recombinant Protein Production Services

Industry-Leading Timelines

Elite Quality

We offer industry-leading timelines from gene synthesis to shipment of your product based on the quality and quantity of protein requested.

• Proprietary codon optimization algorithm generates higher expression and improved protein quality on WuXian Platform • Multiple cell lines and cell culture processes offer more solutions for optimization of product quality • Same vector system and host cell line for transient and stable transfection ensures consistent quality across all production platforms • High-throughput automated expression, purification, and analytic systems • Unique protein production toolbox for bispecific/multispecific antibodies to ensure successful delivery with outstanding efficiency

Timeline 2-7 weeks 3-10 weeks

Quantity unlimited unlimited


Regular antibody

Bispecific/multispecific antibody

COVID-19 antibody expression and purification Completion of COVID-19 antibody IND application

8 days


2.5 months


In special expedited scenarios (e.g., COVID-19/pandemic emergency production), we can deliver gram level quantities of antibody in 8 days or less! For most recombinant proteins, depending on scale and scope of  the production required, the timelines represented here may apply contingent upon protein expression in our cell lines.

WuXi Biologics Protein Sciences

Equipped with the industry-leading expertise, extensive experience, state-of-the-art facilities and proprietary technologies, WuXi Biologics’ PS Department offers our customers the high-throughput, high titer and high purity antibody and protein production for a variety of applications, including but not limited to antibody drug development, small molecular drug targets, animal health, as well as agriculture. With a commitment to innovation and quality, WuXi Biologics’ PS Department is well-positioned to support the growing demand for

Unlimited Capacity

Extensive facilities, high-throughput equipment,  and highly-trained staff available to deliver: • 5,000+ proteins delivered each year • 2,000+ bispecific antibody product experience • 3,000+ antigen product experience • Fast response and immediate initiation of your projects (after receiving AA/DNA sequence) • Diversified expression platforms, including mammalian, E. coli , insect, and yeast • FTE-based service models

antibodies and recombinant proteins services. Our track record of success and strong reputation in the industry make us a trusted partner for clients around the world.

About WuXi Biologics

WuXi Biologics is a leading contract research, development and manufacturing organization (CRDMO) that provides end-to-end capabilities to healthcare organizations worldwide. With operations in China, the United States, Ireland, Germany, and Singapore, we enable our partners to effectively and efficiently bring biologics and vaccines to patients worldwide through our comprehensive and high-quality drug development model. | The world’s leading global single-source platform from concept to commercialization.


Powered by